Looking to the Future: Spotlight on Emerging Biomarkers for Predicting Cardiovascular Risk

Coronary artery disease (CAD) continues to be a major contributor to death and disability worldwide. Emerging biomarkers that are linked to CAD pathophysiology have the potential to phenotype CAD severity and identify individuals at high risk for experiencing future CAD events. This review discusses the utility of emergent biomarkers for CAD risk prediction. Monocytes and neutrophils are key effectors of cardiovascular inflammation, and aspects...